What is the recommended dosage of topical progesterone (a natural hormone) for alleviating perimenopausal symptoms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

For perimenopausal symptoms, topical progesterone cream is typically used at a dose of 20-40 mg per day, applied to thin-skinned areas like the inner wrists, inner arms, or neck, as supported by the most recent study 1. The dose can be started with 20 mg daily (about 1/4 to 1/2 teaspoon of a 2% cream) for the second half of the menstrual cycle (days 14-28) if periods are still regular, or for 14 days per month if periods are irregular. If symptoms persist, the dose can be increased to 40 mg daily. For severe symptoms, some practitioners recommend continuous daily use. Apply the cream at the same time each day, preferably in the evening, and rotate application sites to prevent skin irritation. Results may take 2-3 months to become noticeable. Topical progesterone helps balance estrogen dominance common in perimenopause, reducing symptoms like hot flashes, mood swings, and sleep disturbances, as noted in 2. It works by binding to progesterone receptors throughout the body, helping to restore hormonal equilibrium. Consult with a healthcare provider before starting treatment to ensure appropriate dosing for your specific symptoms and medical history, considering the benefits and risks of hormonal therapy discussed in 3, 4, and 5.

Some key points to consider:

  • The optimal route and dosage of progestin monotherapy have not been established, as highlighted in 1.
  • The available literature is heterogeneous in terms of formulation and dose of progesterone, with administration ranging from 5 to 60 mg of transdermal progesterone, as seen in 1.
  • Side effects, such as headaches and vaginal bleeding, can be significant and lead to discontinuation of treatment, as reported in 1.
  • A beneficial effect was reported in some trials with the transdermal route at longer duration and with oral treatment at higher doses for vasomotor symptoms, as noted in 1.

Overall, the use of topical progesterone cream for perimenopausal symptoms should be individualized and guided by a healthcare provider, taking into account the latest evidence and the specific needs and medical history of each patient, as emphasized in 3, 4, and 5.

References

Research

Management of perimenopause disorders: hormonal treatment.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2021

Research

Management of perimenopausal and menopausal symptoms.

BMJ (Clinical research ed.), 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.